Find a Gynaecologist

Find a GYNAECOLOGIST

Find your nearest Hospital to make an appointment with a gynaecologist to discuss your options and suitability for the Sonata treatment.

All gynaecologists listed have agreed to appear on our website and have the proper equipment and training to offer the Sonata Treatment.

Addenbrooke's Hospital
Hills Road
Cambridge
Cambridgeshire
CB2 OQQ
Tel. 0122 324 5151

Ms Miriam Baumgarten
Ms Emily Gelson
Mr Gerald Hackett

Women were surveyed 12 months after their Sonata Treatment and reported the following results:*
97% of patients would recommend the Sonata Treatment to a friend
95% had a reduction in menstrual bleeding at 12 months (3IbcWwrMQrW)
50% of patients returned to normal activity the next day with an average of 2.2 days

About the Sonata Treatment

The Sonata Treatment is an incision-free treatment for uterine fibroids and has been clinically proven to be safe and effective.*

The Sonata Treatment uses an intrauterine ultrasound handpiece to locate and target the individual fibroids. Radiofrequency energy is delivered to shrink the fibroid and reduce symptoms.

Uterine-Fibroids_04-02

Why is the Sonata Treatment a breakthrough?

Sonata can treat a wide range of fibroid types, sizes, and locations — without even one incision.

The fibroids are treated from inside the uterus, so the Sonata Treatment requires no incisions to the abdomen, no tissue is surgically removed, and the uterus is preserved.

The SONATA Clinical Trial

Women were surveyed 12 months after their Sonata Treatment and reported the following results:*

  • 97% would recommend Sonata treatment to a friend
  • 95% reported a reduction in menstrual bleeding
  • 50% returned to normal activity the next day, with an average of 2.2 days

Intended Use and Safety Information

The Sonata System is intended for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual bleeding.

Contraindications

Current pregnancy; active pelvic infection; known or suspected gynecologic malignancy or premalignant disorders such as atypical endometrial hyperplasia; presence of one or more intratubal implants for sterilization; and presence of an intrauterine device (IUD), unless removed prior to the introduction of the Sonata Treatment Device. View Additional Safety Information.

* Reference for the published clinical trial results: Chudnoff S, Guido R, Roy K, Levine D, Mihalov L, Garza-Leal JG. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas: The SONATA Trial. Obstet Gynecol. 2019 Jan; 133(1): 13-22

Safety Information| Impressum | Terms of Use | Contact Us
Privacy Notice | Cookie Notice | Do not Sell/Share my Personal Information
Limit the Use of My Sensitive Personal Information | Carbon Reduction Plan

Gynesonics, Inc. | 600 Chesapeake Drive | Redwood City, CA 94063 | (650) 216-3860

Copyright 2024  Gynesonics | WS 05195-002UK Rev C